Wegovy was approved in 2021 for chronic weight management in adults who are obese or overweight and have at least one weight-related condition
(2017) published in Diabetes, Obesity and Metabolism demonstrated that semaglutide specifically reduces appetite, food cravings, and the desire to eat energy-dense foods through central nervous system mechanisms
Benefits that accumulate over years of continuous treatment erode rapidly upon stopping
This suggests that exercise may confer some sustained benefit even after discontinuation, whereas pharmacotherapy benefits diminish rapidly when stopped
Take L-carnitine and L-carnosine, for instance: on the surface, they sound very similar but when you look closely, some critical differences make them stand apart
NICE guidance (NG28) typically recommends HbA1c targets of 4858 mmol/mol for most people with type 2 diabetes, though these should be agreed with your healthcare provider based on your specific circumstances